ESC 365 - AV nodal blocking therapy in AF: when, how and for whom?

EHRA Premium Access

AV nodal blocking therapy in AF: when, how and for whom?

Session: Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?

Topic: Atrial Fibrillation (AF)

Speaker: Professor S. Boveda (Toulouse, FR)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Professor Serge Boveda

Clinic Pasteur, Toulouse (France)

26 presentations

7 followers

4 more presentations in this session

The role of digoxin in atrial fibrillation.

Speaker: Professor P. Kirchhof (Hamburg, DE)

The role of a calcium channel blocker in atrial fibrillation.

Speaker: Doctor R. Tieleman (Groningen, NL)

Ablate and pace: the preferred therapy now?

Speaker: Professor P. Vardas (Heraklion, GR)

Is there still room for drugs to control AV nodal conduction in AF? - discussion.

Access the full session

Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?

Speakers: Professor S. Boveda, Professor P. Kirchhof, Doctor R. Tieleman, Professor P. Vardas

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources